How the Treatment of Lung Cancer Has Been Transformed in the Era of Molecular Biomarker Testing

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.

July 29, 2015

How to Improve the Cost of Cancer Treatments

Dr. Alex Adjei addresses the high cost of cancer medicines and suggests various ways to improve cost-effectiveness.

January 30, 2014

Benefits of Congresses and Journals in Educating on Personalized Medicine

Dr Agarwala provides his perspective on the importance of the Global Biomarkers Consortium, World Cutaneous Malignancies Congress and the journal Personalized Medicine in Oncology.